logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    
Aging baby boomers face increased cancer risk, and growing numbers of obese and overweight Americans face metabolic disorders that could lead to cardiovascular disease. Debjit Chattopadhyay of ROTH Capital Partners recommends that biotech investors consider these trends when looking at portfolio options in the healthcare sector. A medical researcher turned…
Read more...
Gilead Sciences Inc. (GILD) posted Q2 2014 earnings of $2.36 a share, easily beating the consensus estimate by 58 cents.Sales came in at $6.53 billion, topping earlier estimate by 12%. More than half of the company’s revenue is generated by its cash cow, Hep C drug Sovaldi. The fruitful earnings…
Read more...
Innocoll GmbH ($INNL) is a global, commercial stage, specialty pharmaceutical company, with late stage development programs targeting areas of significant unmet medical need. It is headquartered in Athlone, Ireland, Ten other companies are scheduled for the week of July 21, 2014. The full IPO calendar is available at IPOpremium. The…
Read more...
Ocular Therapeutix ($OCUL) is a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. It is headquartered in Bedford, MA, Ten other companies are scheduled for the week of July 21, 2014.  The full IPO…
Read more...
Mapi Pharma Ltd. ($MAPI) is a development stage pharmaceutical company, engaged in the development of high-barrier to entry and high-added value generic drugs that include complex APIs, formulations and LCM products that target large markets. It is headquartered in Ness Ziona, Israel, Ten other companies are scheduled for the week…
Read more...
Shares of Puma Biotechnology (PBYI) rocketed to the moon on Wednesday, gaining over 300% at the intraday high. The stock popped on Puma’s PB272 (neratinib) clinical trials, a drug for the treatment of early stage HER2-positve breast cancer. Puma studied 2,821 patients in 41 countries in a double blind, placebo…
Read more...
Immune Design ($IMDZ) is a clinical stage immuno-therapy company with next-generation in vivo approaches designed to enable the body’s immune system to fight disease. It is headquartered in Seattle, WA. Ten other companies are scheduled for the week of July 21, 2014. The full IPO calendar is available at IPOpremium.…
Read more...
The biotech bull market is not over. That's the judgment of Reni Benjamin of H.C. Wainwright & Co., who predicts high quality data from a broad range of small- and mid-cap biotechs will move shares higher during the summer and especially in the fall. In this interview with The Life…
Read more...
Sage Therapeutics ($SAGE) is a biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare central nervous system, or CNS, disorders, where there are inadequate or no approved existing therapies. It is headquartered in Cambridge, MA, Eleven other companies are scheduled for the week of July 14,…
Read more...
Pfenex ($PFNX) was a December 2009 spinout from The Dow Chemical Company (DOW) headquartered in San Diego, CA, Eleven other companies are scheduled for the week of July 14, 2014. The full IPO calendar is available at IPOpremium. The manager and co-managers are William Blair and JMP Securities. The joint manager…
Read more...
Hospital operator HCA Holdings Inc. (HCA) is up 10.4% Tuesday to $61.37 per share on Wednesday, July 16, after the hospital pre-announced stronger than expected 2014 second-quarter results.  HCA posted $1.07 EPS at estimated $9.23 billion revenue, beating an estimate in a Thomson Reuters poll of analysts' of 91 cents per…
Read more...
Roka Bioscience ($ROKA) is a molecular diagnostics company initially focused on providing advanced testing solutions for the detection of foodborne pathogens headquartered in Warren, N.J. Eleven other companies are scheduled for the week of July 14, 2014. The full IPO calendar is available at IPOpremium. The manager and co-managers are BofA…
Read more...
Page 1 of 44

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.